<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nonrandom chromosomal abnormalities are found in most human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, particularly <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A characteristic t(1;19) (q23;p13.3) chromosomal translocation is detected in 5% of childhood <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) cases </plain></SENT>
<SENT sid="2" pm="."><plain>This translocation results in the formation of a fusion gene, which leads to the expression of an oncogenic E2A/pbx1 protein </plain></SENT>
<SENT sid="3" pm="."><plain>Breakpoints in the E2A gene almost invariably occur within a single intron, and the identical portion of PBX1 is joined consistently to exon 13 of E2A in fusion <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In this article, we report the development of monoclonal antibodies against E2A/pbx1 fusion protein using a specific <z:chebi fb="7" ids="16670">peptide</z:chebi> that corresponds to the junction region of the protein </plain></SENT>
<SENT sid="5" pm="."><plain>The obtained antibodies recognize specifically the chimeric E2A/pbx1 fusion protein and lack cross-reactivities with E2A and pbx1 </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemical staining and flow cytometric studies show that these antibodies can distinguish t(1;19)-positive from t(1;19)-negative leukemic cells </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that the obtained E2A/pbx1-specific monoclonal antibodies might prove to be valuable diagnostic reagents and important tools for elucidating the mechanisms involved in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> and progression of t(1;19)-positive <z:e sem="disease" ids="C0023452" disease_type="Neoplastic Process" abbrv="">childhood ALL</z:e> </plain></SENT>
</text></document>